~~<i id='674D108DC1'><strike id='674D108DC1'><tt id='674D108DC1'><pre id='674D108DC1'></pre></tt></strike></i>~~

00:00

00:00 00:00 LIVE

buffering

Replay

focus

author：hotspot 2025-10-01 14:19:40 - browse：24274

the shape of a medical note connected by dots and lines — health tech coverage from STAT — Adobe

In recent months, the federal government has repeatedly told Medicare Advantage insurers that they cannot use artificial intelligence or algorithms to deny medical services the government routinely covers.

But in finalizing a rule to that effect, it also stepped into a thicket of questions from insurers about a technology that is especially difficult to pin down: What is AI? Can it be used at all to make decisions about the coverage of older patients? If so, how?

This week, the federal agency that oversees Medicare sought to boil it all down into a simple directive: Put the circumstances of the individual patient first, and your algorithm second.

Get unlimited access to award-winning journalism and exclusive events.

Subscribe Log In

Previous article： United colonoscopy coverage change 'may cost lives,' doctors say
Next article： NIH study of ME/CFS points to clear biological hallmarks

hotspot

explore

Wikipedia

explore

hotspot

AFP/GettyImagesMostofthetime,it’seasytobeintheplacebogroup ofaclinicaltrial:nosideeffects,minimalann

WSS

Antibiotic resistance and the global rise in human conflict

Videos point to link between seizures and unexplained toddler deaths

Ed Silverman on new gene therapies, biosimilars, coffee, and more

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

Obesity drugs seen as possible treatment for liver disease MASH

Ocular Therapeutix moves raise hopes, and Alnylam tries to calm some nerves

focus

focus

hotspot

Biden outlines 'new path' to provide student loan relief after Supreme Court rejection

At JPM, Bristol Myers Squibb CEO tries to soothe investor nerves

Wildfire smoke exposes gaps in outdoor worker protections

6 phony surgeries that take placebo to the extreme

Anesthesiologist group: stop taking Ozempic before surgery

Federal weight loss drug coverage is 30 years out of date

ChatGPT in medicine: STAT answers readers' burning questions

He's a Nobel laureate. Critics say he was misleading on Covid

The cancer drug shortage isn’t new — and neither are the solutions

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

explore

Alabama IVF ruling threatens families facing fatal genetic disease

Alabama hospital puts IVF treatments on hold

6 phony surgeries that take placebo to the extreme

Susan Tousi leaves Illumina to head cancer liquid biopsy startup

Readout Newsletter: Allogene's pivot, Illumina exec to lead Delfi

The Readout: Abbvie and Humira, CRISPR in utero, Annovis Bio

Wikipedia

explore

hotspot

hotspot